Runway Growth Finance Corp. Provides First Quarter 2024 Portfolio Update
MENLO PARK, Calif., April 09, 2024 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), […]
Great Elm Capital Corp. Announces Public Offering of Unsecured Notes
PALM BEACH GARDENS, Fla., April 09, 2024 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced […]
Leading German Auto Finance Company Goes Live with Full NFS Ascent Suite to Support Operations in South Korea
ENCINO, Calif., April 09, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), the global leader in delivering state-of-the-art solutions […]
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
BASKING RIDGE, N.J., April 09, 2024 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage […]
LM Funding America, Inc. Provides Monthly Operational and Bitcoin Mining Update for Month Ended March 31, 2024
TAMPA, FL, April 09, 2024 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a […]
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
HORSHAM, Pa., April 09, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical […]
Microchip Brings Enhanced Code Protection and up to 15W of Power Delivery to its USB Microcontroller Portfolio
CHANDLER, Ariz., April 09, 2024 (GLOBE NEWSWIRE) — The well-known advantages of a Universal Serial Bus (USB) interface for embedded designs […]
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
CARLSBAD, Calif., April 09, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or the “Company,” Nasdaq: QLGN) today announces that […]
Star Bulk Completes Merger With Eagle Bulk
ATHENS, Greece, April 09, 2024 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (“Star Bulk”) (Nasdaq: SBLK), a global shipping company […]
